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Abstract
mRNAs can be targeted to specific neuronal subcellular domains, which enables rapid changes in
the local proteome through local translation. This mRNA-based mechanism links extrinsic signals
to spatially restricted cellular responses and can mediate stimulus-driven adaptive responses such
as dendritic plasticity. Local mRNA translation also occurs in growing axons where it can mediate
directional responses to guidance signals. Recent profiling studies have revealed that both growing
and mature axons possess surprisingly complex and dynamic transcriptomes, thereby suggesting
that axonal mRNA localization is highly regulated and has a role in a broad range of processes, a
view that is increasingly being supported by new experimental evidence. Here, we review current
knowledge on the roles and regulatory mechanisms of axonal mRNA translation and discuss
emerging links to axon guidance, survival, regeneration and neurological disorders.
Cell–cell signalling relies on the ability of cells to adjust their local proteome (protein
abundance and complexity) with high spatiotemporal precision in response to extracellular
signals. Thousands of mRNAs exhibit specific subcellular localization patterns in mammals1
and in Drosophila melanogaster2, which suggests that local mRNA translation may have a
general role in controlling the local proteome. Conceptually, local protein synthesis provides
several advantages over the transport of pre-existing proteins from one part of the cell to
another3. First, translationally silent forms of mRNAs can be stored locally and used to
make many copies of a protein when needed, thereby providing economic advantages.
Second, the ectopic presence of proteins in other parts of the cell during protein transport is
avoided. Third, mRNAs can be targeted to different subcellular localizations using ‘address’
information in their untranslated regions (UTRs) without changing the structure and function
of the proteins they encode. Finally, properties that are unique to newly made proteins (such
as minimal post-translational modification) may provide an additional layer of signalling
information.
Intuition suggests that highly polarized cells like neurons would benefit greatly from local
mRNA translation. Indeed, local mRNA translation is known to mediate long-lasting
synaptic plasticity in dendritic spines, and studies in dendrites have provided significant
mechanistic and functional insights into how extrinsic signals regulate local mRNA
translation4,5. Although evidence for axonal protein synthesis in mammals dates back to the
1960s6–8, surprisingly little is known about local mRNA translation in axons. The general
view of the axon as a passive transmitter of information may have contributed to this
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neglect. Nevertheless, axons — like dendrites — are signal-receiving compartments.
Growing axons require extrinsic signals to regulate their growth, navigation and synapse
formation and mature axons depend on external cues for maintenance and repair. Thus, there
is clearly a conceptual need for local protein synthesis in distal axons9. Indeed, stimulus-
induced responses of axons in cell culture — such as chemotropic responses10 and
regeneration following injury11 — require axonal mRNA translation, and evidence suggests
that some of these findings could be applicable in vivo12–14.
Thus, local mRNA translation can be regarded as a common mechanism for the regulation
of local proteomic homeostasis in response to extracellular signals in axons and dendrites.
Both developing15,16 and mature17,18 axons contain complex and dynamic mRNA
repertoires, and recent studies have provided insights into the regulation of axonal mRNA
translation. Here, we aim to provide a conceptual framework for this emerging field of
active research by reviewing our understanding of the current literature and discussing
future directions.
Evidence for axonal mRNA translation
The initial lack of interest in local axonal mRNA translation can be traced back to findings
in the 1970s using the squid giant axon. It was suggested that protein synthesis is unlikely to
occur in mature axons as little or no ribosomal RNA (as measured by their optical densities
on polyacrylamide gels) was observed in the axoplasm19. This interpretation was, however,
later disputed by evidence obtained using more sensitive biochemical methods showing the
presence of ribosomal RNAs20, mRNAs21 and actively translating polysomes22 in squid
giant axons. In mammals, ribosomes were identified by electron microscopy in embryonic
cortical23 and sympathetic24 neuronal axons in cell culture, and in embryonic peripheral
sensory axons in vivo25. Recent immuno-electron microscopy has shown specific
immunoreactivity to the ribosomal protein S6 in the axons of cultured embryonic
sympathetic and hippocampal neurons26. Notably, axonal ribosomes rarely form polysomes
in vivo24,25,27, unlike in culture conditions23, which suggests that monosomal translation
may predominate or that translational activation is spatiotemporally restricted in axons in
normal conditions.
In an electron microscopy study using adult rats, electron-dense ribosomal rosettes — the
typical ultrastructural appearance of polysomes — were limited to the axon initial segment
and not detectable in the axon shaft of CNS neurons28, thus leading to speculation that
axonal protein synthesis only occurs during development. Immunohistological studies,
however, showed that mature PNS axons contain ribosomal proteins and RNAs, which form
intermittent ribosomal plaques that are distributed unevenly in the peripheral axoplasm close
to the plasma membrane29–32. These observations were consistent with an overlooked
electron microscopy study from 1970 (REF. 33). The peripheral localization of ribosomes
also agrees with a recent finding that a direct interaction between cell surface receptors and
ribosomes spatially restricts mRNA translation to the site at which an extrinsic cue is
received26. The specialized morphology and distribution of axonal ribosomes may thus have
made their ultrastructural identification difficult28. Indeed, immuno-electron microscopy
evidence from transgenic mice showed that an enhanced green fluorescent protein (EGFP)-
tagged ribosomal protein L10a (EGFP–L10a) localizes to the nodes of Ranvier in
corticospinal tract axons in vivo34. Although some EGFP–L10a may be present outside the
ribosome (as it probably competes with endogenous L10a for ribosomal occupancy), this
nonetheless supports the idea that mature axons contain intermittent ribosomal plaques that
are not readily identifiable by conventional ultrastructural criteria29–33.
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Compelling evidence for axonal protein synthesis came from metabolic labelling
experiments that showed that unmyelinated axons without somas are capable of mRNA
translation-dependent protein synthesis in vertebrates7,35–39 and invertebrates6,21. Another
key finding was that exogenous mRNA can be translated when injected into mollusc axons
without somas40. The list of axonally localizing and translatable mRNAs is rapidly growing
and includes those encoding membrane-targeted proteins such as ephrin type-A receptor 2
(EPHA2)41 and κ-type opioid receptor (KOR1; also known as OPRK1)42.
Several electron microscopy studies have failed to identify rough endoplasmic reticulum
(RER) and Golgi apparatus in vertebrate axons24,25,27,43, thus raising the question of
whether vertebrate axons have the capacity to process proteins. However, a recent study
using the severed axons of cultured peripheral sensory neurons showed that metabolically
labelled, newly synthesized proteins are trafficked to the plasma membrane44, thus
suggesting that the functional equivalent of RER and Golgi apparatus exists in these axons.
ER-associated and Golgi-associated proteins have been detected immunocytologically in the
axons of vertebrates44, but the morphology of the axonal ER is distinct from that found in
the soma44,45. These findings are consistent with those seen in invertebrates. Mollusc axons
are capable of local protein targeting but do not appear to possess ultrastructurally
identifiable RER and Golgi apparatus46. Nevertheless, proteins residing in the ER and Golgi
can be detected immunocytologically47. It will be interesting to explore whether the axonal
RER and Golgi adopt specialized morphologies, perhaps similar to those of primitive
parasites48. Together, these findings show that both growing and mature axons possess
protein synthesis and processing machinery, but the unconventional nature of their
histological structure presents a puzzle.
Function of axonal mRNA translation
Growing axons receive continuous guidance information from their environment as they
travel along long stereotypical paths to reach their synaptic partners. The distal tip of a
growing axon, a specialized structure known as the growth cone, must quickly process this
information, often without enough time to communicate with its soma. Indeed, axons
severed from their cell bodies can correctly pathfind in vivo49, and the growth cone can
respond to guidance cues without the cell body in vitro10,50.
Local mRNA translation is a key mechanism in this autonomous signalling, and protein
synthesis inhibitors block the ability of growth cones that are severed from their somas to
respond to several guidance cues. These guidance cues include netrin 1 (REFS 51–54),
semaphorin 3A (SEMA3A)10,55, SLIT2 (REF. 56), engrailed 1 and engrailed 2 (EN1 and
EN2)57–59, pituitary adenylate cyclase-activating polypeptide (PACAP; also known as
ADCYAP1)60, nerve growth factor (NGF)52,61, brain-derived neurotrophic factor (BDNF)54
and neurotrophin 3 (NT3)62,63. Increasing evidence shows that axonal mRNA translation
continues to play roles in adulthood, particularly during plastic responses such as injury-
induced axon regeneration11,13,14,64–66. These extrinsic factors rapidly induce local protein
synthesis by activating the mammalian target of rapamycin (mTOR) pathway (TABLE 1).
Chemotropic responses of growth cones
One of the first identified functions of axonal protein synthesis was its ability to mediate
netrin 1-induced and sema3a-induced chemotropic responses in cultured growth cones10
(FIG. 1). Xenopus laevis retinal growth cones without somas turn towards netrin 1 gradients
and away from sema3a gradients in culture10. Application of these cues to soma-less growth
cones increases mTOR activity (as measured by phosphorylation of its substrate eukaryotic
translation initiation factor 4E (eIF4E)-binding protein 1 (4e-bp1)) and axonal protein
synthesis (as measured by 3H-leucine incorporation) within minutes. In addition, inhibiting
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mTOR activation (with rapamycin) or ribosome function (with cycloheximide or
anisomycin) blocks both local protein synthesis and the chemotropic responses10. Inhibition
of mTOR or protein synthesis also blocks sema3a-induced growth cone collapse (the rapid
withdrawal of filopodia in response to uniformly applied repulsive cues)10. Intriguingly, a
phosphoinositide 3-kinase (PI3K) inhibitor blocks the growth cone’s response to netrin 1,
whereas the response to sema3a is not blocked. This suggests that different signalling
pathways downstream of netrin 1 and sema3a converge on mTOR10. Lysophosphatidic acid-
induced growth cone collapse is not affected by any of these inhibitors, and
lysophosphatidic acid application increases neither mTOR activity nor local protein
synthesis10. Other cues that do not induce protein synthesis include ephrin B67 and
sphingosine 1-phosphate68.
Interestingly, SEMA3A-induced, protein synthesis-dependent growth cone collapse occurs
at low, but not at high, concentrations of SEMA3A69. This agrees with the finding that
growth cones lose their physiological cue selectivity when the cues are applied in high
concentrations69. For example, spinal motor neuron growth cones show neuronal subtype-
specific collapse responses to either SEMA3A or SEMA3F in culture, and these responses
are blocked by protein synthesis inhibitors69. When these cues are applied in high
concentrations, the growth cones lose both cue specificity and protein synthesis
dependence69. Differences in the concentration and/or bioactivity of SEMA3A may
therefore account for discrepancies in the literature regarding the protein synthesis
dependence of SEMA3A-induced growth cone collapse10,55,70.
Although the detailed mechanisms vary, most protein synthesis-inducing cues seem to
activate the translational machinery through the mTOR pathway10,56,58 and the direction of
turning responses by growth cones is determined by the specific mRNAs that are translated.
For example, stimulating growth cones with a netrin 1 or BDNF gradient results in rapid
trafficking of β-actin mRNA to the side of the growth cone nearest the gradient, resulting in
asymmetric β-actin synthesis that is rapamycin-sensitive53,54. Zipcode binding protein 1
(ZBP1; also known as VG1RBP), an RNA-binding protein (RBP), transports β-actin mRNA
in a translationally silent state by binding to a cis-acting element zipcode in its 3′-
UTR53,54,63 and repressing its translation71. Attractive growth cone turning towards netrin 1
or BDNF can be prevented by inhibiting β-actin synthesis using antisense oligonucleotides
that block translation53 and by disrupting the β-actin mRNA–ZBP1 interaction with
antisense zipcode oligonucleotides54 or sense zipcode oligonucleotides that competitively
inhibit endogenous β-actin mRNA13. Attractive growth cone turning can also be prevented
by genetically deleting ZBP1 (REF. 72); these all suggest that cue-induced β-actin synthesis
is required for this process in culture. By contrast, the repulsive cues SLIT2 and SEMA3A
do not elicit β-actin synthesis, but induce rapid axonal synthesis of proteins that promote
actin disassembly such as cofilin56 and RHOA55. SEMA3A-induced growth cone collapse
can be blocked by inhibiting axonal RHOA mRNA translation55.
These findings led to the development of the differential translation model (FIG. 1),
whereby the direction of growth cone turning is determined by the localized synthesis of
proteins that promote either assembly (mediating attraction) or disassembly (mediating
repulsion) of the cytoskeleton73. This agrees with studies in fibroblasts that show a
requirement for the localization of β-actin mRNA to the leading lamellipodia for cell
polarization and motility74,75. Given that pre-existing β-actin monomers are abundant in
growth cones and that local mRNA translation in fibroblast lamellipodia gives no clear
temporal advantage over transporting pre-existing β-actin monomers, the primary role of de
novo β-actin synthesis probably lies in the spatial bias it provides to the polarization of
cytoskeletal dynamics. For example, newly synthesized β-actin that lacks post-translational
modifications (such as arginylation76 and glutathionylation77) could provide a more efficient
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nucleation signal than pre-existing monomers and thus seed actin polymerization on the
nearside of the growth cone in an attractive gradient, thus driving growth in this direction.
Conversely, polarized disassembly of the cytoskeleton on the nearside of a repulsive
gradient would steer axons away from the gradient; however, this idea has not yet been
tested. Nevertheless, it is noteworthy that cytoskeletal-associated molecules are highly
represented in the axonal transcriptome15–18 (TABLE 2).
It is not yet clear what specific aspects of axonal pathfinding in vivo correspond to these in
vitro findings. Although there is no reported axon guidance defect in mice with only one
functional Zbp1 allele72, the peripheral sensory neurons of these mice, as well as those of
mice overexpressing zipcode competitive inhibitors, exhibit reduced axon branching in
culture13. Similarly, blocking the ubiquitin–proteasome system in vivo results in cell
intrinsic defects in retinal axon branching but does not affect long-range pathfinding78.
However, chemotropic responses of cultured growth cones to netrin 1 are blocked either by
a proteasome or translation inhibitor alone10. Therefore, growth cone chemotropic responses
in vitro may reflect short-range, cue-induced events, such as axon branching. It remains to
be seen which particular processes are regulated by axonal mRNA translation in vivo.
Growth cone adaptation and gradient sensing
Growth cones must sense chemical gradients in order to properly guide their axons79.
Growth cone adaptation, which is crucial for gradient sensing, involves successive cycles of
desensitization and resensitization of the growth cone to an extracellular signal, and the
resensitization step requires axonal protein synthesis50,80. Cultured X. laevis embryonic
spinal neuronal growth cones lose their ability to respond to netrin 1 or BDNF after
preincubation with the cue but regain responsiveness after 60–90 minutes in a manner that is
sensitive to a translational inhibitor50. This enables these growth cones to respond to a netrin
1 or BDNF gradient many times in a lengthy period of exposure, which results in a zigzag
pattern of growth50. This homeostatic reset mechanism is likely to be efficient for rapidly
elongating axons that need to take only intermittent bearings to steer towards a distant cue.
Adaptation can also occur on a shorter timescale80. Cultured X. laevis retinal axons briefly
preincubated with a low dose of repulsive sema3a or netrin 1 (netrin 1 can be either
attractive or repulsive depending on the context81,82) lose their ability to respond to a
collapse-inducing dose of the same cue80. This rapid (1–2 minutes) desensitization is cue-
specific and mediated by ligand-induced receptor endocytosis80. Desensitized growth cones
regain responsiveness in 4 minutes in a translation-dependent manner, but a higher dose of
netrin 1 or sema3a is now required to induce the same degree of growth cone collapse80.
This rapid recalibration mechanism allows advancing growth cones to readjust their
sensitivity quickly and to compare minute differences in a concentration gradient.
Interestingly, both receptor endocytosis and translation are spatially polarized to the gradient
nearside of growth cones83, which suggests that the two processes are intimately linked.
Changes at intermediate targets
Growth cones encounter different guidance cues along their pathway and change cue
responsiveness while they travel. For example, X. laevis retinal axons are attracted towards
netrin 1 expressed in the optic nerve head, but netrin 1 becomes repellent upon exit from the
eye81,82. Such switches might be regulated by local translation in distal axons.
In chick commissural axons transfected with a fluorescent reporter protein mRNA — the
translation of which is regulated by the 3′-UTR of the ephrin A receptor epha2 mRNA
(BOX 1) — increased reporter expression was observed in distal axons that had passed the
midline of the spinal cord41. Although it is unknown whether endogenous epha2 mRNA is
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localized and regulated in this manner, this suggests the possibility that intermediate targets
regulate the future responsiveness of axons by stimulating local synthesis of new guidance
cue receptors. The expression of robo3, a receptor for slits that repels axons at the midline, is
also regulated at the translational level84. It will be interesting to determine whether mRNAs
encoding this and other receptors are axonally translated and regulate axon guidance in vivo.
Axon elongation
The short-term basal growth of axons does not require axonal protein synthesis36, and
severed axons grow normally for 2–5 hours in the presence of protein synthesis inhibitors in
culture10,53,85. Cue-induced axon growth promotion does, however, require axonal protein
synthesis52,86. NGF and netrin 1, when applied acutely to cultured mammalian sensory and
commissural neurons, respectively, promote axon outgrowth. Axonal synthesis of
proteinase-activated receptor 3 (PAR3), a component of a complex that controls cytoskeletal
dynamics, is required for NGF-induced and netrin 1-induced axon outgrowth52. β-thymosin,
which prevents actin polymerization, is locally synthesized in cultured mollusc neurites
treated with brain lysate, and inhibiting the translation of β-thymosin mRNA in isolated
neurites promotes their elongation86. These studies suggest that extrinsic signals might
shape the pattern of axonal outgrowth by regulating local synthesis of positive and negative
regulators of cytoskeletal dynamics.
Synapse formation
Upon reaching its target, the growth cone transforms into the presynaptic terminal, which is
highly branched and enriched with synaptic vesicles. Comparative subcellular mRNA
profiling analysis has revealed that mRNAs encoding proteins implicated in this process
(branch-promoting proteins and synaptic vesicle proteins) become specifically enriched in
the growth cone as X. laevis retinal ganglion cells mature in culture16. Thus, these mRNAs
are trafficked to the growth cone to coincide with target arrival and might be translated in
response to target-derived cues. Indeed, presynaptic protein synthesis is required for BDNF-
induced and NT3-induced potentiation of synaptic vesicle release in cultured X. laevis lower
motor neurons62,87. Presynaptic protein release is also required for an increase in synaptic
vesicle number with synaptic maturation in cultured mouse hippocampal neurons88.
This finding is in accordance with studies using mollusc neurons, which show that
presynaptic protein synthesis89 is required for synapse formation47,90–92. It is also in
agreement with a study of the Drosophila melanogaster neuromuscular junction, which
shows that 3-phosphoinositide-dependent protein kinase 1 (PDK1) and ribosomal protein S6
kinase (S6K) — which are both components of the mTOR pathway — control synaptic
bouton size, active zone number and synaptic function, although translation-dependency has
not been tested in this case93. Furthermore, fragile X mental retardation protein (FMRP), a
known translational regulator and mediator of synaptic plasticity in dendritic spines94,95, is
found in axons and growth cones96–98, and its loss leads to a cell autonomous defect in the
formation of presynaptic terminals in organotypic mouse hippocampal slices99. Other
translational regulators such as survival of motor neuron (SMN1)100,101 and Hu-antigen D
(HUD; also known as ELAVL4)102,103 also localize to axons and growth cones, thus
indicating a probable broad presynaptic role of translation in aspects of synapse formation.
Transmitter biogenesis
Nerve terminals that secrete neurotransmitters remotely from their cell bodies might benefit
from local mRNA translation. Indeed, a metabolic labelling study carried out in the 1960s
using rat brains showed that newly (15–90 minute) synthesized proteins localize to nerve
endings104. There is evidence suggesting that enzymes that regulate neurotransmitter
metabolism, such as tyrosine hydroxlase (a key regulator of catecholamine biogenesis) and
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acetylcholinesterase (AChE; an enzyme that degrades acetylcholine), might be synthesized
in nerve terminals.
A drug-induced increase in tyrosine hydroxlase activity105 and the reappearance of AChE
activity after irreversible pharmacological inactivation106 occur in nerve terminals at speeds
that cannot be explained by axonal transport from the cell bodies. Tyrosine hydroxlase
mRNAs can be detected in the striatum by reverse transcription-polymerase chain reaction
and in situ hybridization and is decreased by pharmacological lesion to the nigrostriatal
pathway107.
Neuropeptides and hormones might also be synthesized in nerve terminals. Oxytocin and
vasopressin mRNAs can be detected in the neurohypophysis by reverse transcription-
polymerase chain reaction, in situ hybridization and northern blot108–112, and several
invertebrate hormones can be locally synthesized in isolated axons47,90–92,113. However,
whether these proteins are synthesized in the nerve endings in vivo and whether axonally
synthesized proteins can be secreted is unknown.
Cell survival and axon maintenance
The promotion of axon survival by target-derived trophic factors can also be considered an
adaptive response to extrinsic cues, and appears to involve axonal protein synthesis. For
example, NGF supports the survival of cultured peripheral sensory and sympathetic neurons
in a translational inhibitor-sensitive manner15,61,114. In cultured sympathetic neurons,
inositol monophosphatase 1 (IMPA1) is axonally synthesized in response to NGF, and
initiates an unknown signalling cascade that relays a survival signal to the nucleus15 (FIG.
2a). In cultured peripheral sensory neurons, the transcription factor cyclic AMP responsive
element-binding protein (CREB) is axonally synthesized in response to NGF and
retrogradely transported to the nucleus where it initiates transcription-dependent cell
survival mechanisms61 (FIG. 2a). Interestingly, axonally synthesized CREB is specifically
required for the NGF-induced survival signal: CREB synthesized in the cell body is unable
to mediate NGF-induced cell survival61. This effect may be cell type-specific, because
CREB mRNAs are found exclusively in peripheral sensory neurons17,61.
Axonally synthesized proteins can also support axon survival locally by promoting
mitochondrial function. Many axons contain nuclear-transcribed mRNAs encoding
mitochondrial proteins115–117 or proteins involved in mitochondrial function15–18 (TABLE
2). Axon-specific inhibition of mRNA translation or mitochondrial protein import decreases
mitochondrial membrane potential in cultured sympathetic neurons117, thus suggesting that
nuclear-encoded mitochondrial proteins are locally synthesized and imported to axonal
mitochondria to support their function. New evidence shows that this mechanism may
operate in vivo118. In cultured X. laevis retinal axons, target-derived cues such as en1
stimulate the local synthesis of lamin B2, a component of the nuclear lamina, which,
surprisingly, then localizes to axonal mitochondria118 (FIG. 2a). Sustained axonal
translation of lamin B2 mRNA is required for mitochondrial function in vitro and axon
maintenance in vivo118. Interestingly, en1 also induces the synthesis of nuclear-encoded
mitochondrial proteins in midbrain dopaminergic neurons in mice and supports their
survival57. Therefore, stimulating the local synthesis of proteins involved in mitochondrial
function might be a common mechanism by which target-derived cues support axon
maintenance. Intriguingly, mutations in either mitochondrial proteins119 or lamins120 can
cause Charcot–Marie–Tooth disease type 2, a neuropathic disorder that is characterized by
chronic axonal degeneration. Together, these suggest links among mitochondria, lamins and
axon maintenance.
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Response to nerve injury and axon regeneration
As local mRNA translation mediates adaptive responses to extracellular signals, it is not
surprising that mRNA translation can occur even in mature axons, especially during plastic
responses such as regeneration. Generally, the ability of axons to synthesize proteins
decreases as they mature, which has been associated with a coincident reduction in their
ability to re-grow after axotomy121,122. Indeed, axons preconditioned with nerve injury in
vivo show increased local protein synthesis11,38,39,43,64 and regeneration11 in vitro, and
further increasing mTOR activity at the injury site (by locally applying phosphatase and
tensin homologue (PTEN) short interfering RNA (siRNA) or the PTEN inhibitor
bisperoxovanadium) promotes regeneration in vivo123. Intriguingly, there is evidence
suggesting that axonal protein synthesis might be augmented after nerve injury by an
unconventional mechanism of transceullar ribosomal delivery from glial cells124,125.
Critically, blocking mRNA translation in severed axons inhibits the regeneration of new
growth cones in culture11, and mice with reduced activity of ZBP1 exhibit attenuated axon
regeneration after nerve injury in vivo13. These findings suggest that the ability of axons to
locally synthesize proteins is related to their ability to regenerate. Indeed, olfactory sensory
neurons, which naturally regenerate their axons, contain multiple axonal mRNAs126,127,
some of which associate with axonal polysomes in vivo128.
In peripheral sensory neurons, nerve injury generates a cascade of retrograde signalling
events that ultimately activates transcription of genes required for axon survival and
regeneration129 (FIG. 2b). Local synthesis of transcription factors, such as signal transducer
and activator of transcription 3 (STAT3), at the injury site is required for generating this
signal14. Newly synthesized STAT3 is locally phosphorylated and retrogradely transported
in an active state14. This is similar to CREB, which is locally synthesized and activated by
NGF58. Intriguingly, the retrograde transport itself is also regulated by local mRNA
translation. Ran GTPase, a regulator of nuclear transport, localizes to axons in a GTP-bound
state in normal conditions, preventing cargo proteins from binding to the importin-α–dynein
motor complex that is involved in retrograde transport66. Nerve injury induces local
synthesis of Ran-specific GTPase-activating protein (RANBP1)66 and importin-β1 (REF.
64), which displaces Ran GTPase and directly binds to importin-α, respectively. The
importin-α–importin-β1–dynein motor complex binds to transcription factors bearing
nuclear localization signals, thus enabling their retrograde transport. Vimentin, which is also
locally synthesized in response to injury, also directly binds to importin-β1 and other
signalling molecules such as extracellular signal-regulated kinase 1 and 2 (ERK1/2), thereby
facilitating the relay of complex information to the cell body65.
Surprisingly, local application of membrane-permeable nuclear localization signal peptides
— which prevent axonally synthesized transcription factors from binding to importin-β1 —
at the time of nerve injury abolishes the positive effect of preconditioning lesion to axon
regeneration in vitro64 and neuronal survival in vivo14. Local translation of transcription
factors might be an evolutionarily conserved mechanism to protect axons, because axonal
translation of CAAT enhancer binding protein 1 (cebp-1) mRNA is required for axon
regeneration after axotomy in Caenorhabditis elegans130.
In the CNS, axons lose their ability to regenerate in adulthood. Intriguingly, increasing
protein synthesis might restore their regenerative potential131. In mice, global translational
activity (as measured by the phosphorylation of the ribosomal protein S6) in retinal ganglion
cells decreases with age132,133. In contrast to peripheral axons11, injury to postnatal retinal
axons downregulates global translational activity in retinal ganglion cells in vivo131.
Intriguingly, genetic deletion of the negative regulators of mTOR, PTEN and tuberous
sclerosis protein 1 (TSC1), prevents this decrease in translational activity131. Remarkably,
these rejuvenated neurons can regenerate axons, although whether axonal or somal protein
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synthesis plays a more important role in this effect is unknown131. Thus, different
translational responses to nerve injury might account for the different abilities of CNS and
PNS neurons to regenerate axons.
Receptor expression and pain regulation
Some evidence suggests that local mRNA translation may regulate pain sensitivity. mRNAs
encoding transient receptor potential cation channel subfamily V member 1 (TRPV1), a
capsaicin-gated and high temperature-gated ion channel, are detected in the axons of
peripheral nociceptors in adult mice134. Interestingly, inflammatory insults increase the
axonal transport of Trpv1 mRNA to central endings in the spinal cord, and intrathecal
delivery of Trpv1 antisense oligodeoxynucleotides reduces the inflammation-induced
TRPV1 hypersensitivity in spinal cord slices134. Nerve injury also induces specific
accumulation of tetrodotoxin-resistant voltage-gated sodium channel 1.8 (Nav1.8) mRNA in
injured axons in vivo135. Subcutaneous injection of Nav1.8 siRNA into areas in which
peripheral endings terminate specifically reduces Nav1.8 mRNA in the axon but not in the
cell body, and reduction of axonal Nav1.8 mRNA correlates with the reversal of neuropathic
pain in mice135. Furthermore, delivery of inhibitors of protein synthesis either intrathecally
(rapamycin136 and cycloheximide134) or intraplantarly (rapamycin137 and anisomycin138)
alleviates pathological pain in mice, although these effects may indirectly result from the
decreased production and release of pro-inflammatory cytokines from neighbouring cells.
The axons of cultured peripheral sensory neurons also contain mRNAs encoding KOR1, a
GPCR that generates an antinociceptive signal, and the axonal localization of Kor1 mRNA
is enhanced by depolarization in culture42,139. Direct evidence showing that these receptors
are trafficked to the plasma membrane is still lacking, although these axons have functional
machinery to target proteins to the cell surface44 and mollusc axons can target locally
synthesized conopressin receptor to the plasma membrane46.
Neurodevelopmental and neurodegenerative disorders
Numerous neurodevelopmental disorders, such as fragile X mental retardation and autism
spectrum disorders, seem to share dysregulated protein synthesis as an underlying cause of
clinical pathologies140. Although dendrites are well-documented sites of synaptic
pathology140, there is less evidence for axons. Recent evidence, however, shows that
translational regulators such as FMRP, also localize to axons and regulate presynaptic
function99. Therefore, dysregulated axonal mRNA translation may, in future, be found to
contribute to clinical pathologies of neurodevelopmental disorders141.
Recent evidence links axonal mRNA translation to neurodegenerative diseases, such as
spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). SMA is
characterized by lower motor neuron degeneration and muscular atrophy and is caused by
deletions in SMN1 (REF. 142). SMN1 associates with small nuclear ribonucleoproteins
(snRNPs) in the nucleus to regulate pre-mRNA splicing143 but also localizes to axons and
growth cones144,145. In the cytoplasm, SMN1 regulates mRNA translation by forming RNA
granules with FMRP146, thereby suggesting that defective axonal mRNA translation may
contribute to SMA. Indeed, SMN1 positively regulates the translation of candidate
plasticity-related gene 15 (cpg15; also known as NRN1) mRNA in axons by interacting with
HUD, and, remarkably, overexpressing cpg15 partially rescues SMN1 loss-of-function
phenotype in zebrafish12. Therefore, the regulation of axonal mRNA translation by SMN1
may be required for the maintenance of these axons. ALS is the most common motor neuron
disease in adults147 and is associated with mutations in genes encoding RBPs such as TAR
DNA-binding protein 43 (TDP43), RNA-binding protein FUS (FUS), and angiogenin148,149.
These mutations commonly increase the numbers of stress granules, which reversibly
sequester mRNAs and repress their translation150. Because sustained translation of axonal
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mRNAs is required for axon maintenance12,117,118, decreased axonal mRNA translation
caused by these mutations might contribute to axon degeneration in ALS.
Regulation of axonal mRNA translation
Global translational activity
The rate of protein synthesis in cells is tightly coupled to their nutritional status: cells
increase protein synthesis when they receive growth-promoting signals. This cellular
homeostasis is regulated by mTOR, which activates translational initiation by
phosphorylating its two major substrates 4E-BP1 and S6K132,133. Accumulating evidence
shows that local protein synthesis in axons and growth cones is also regulated through
mTOR. Protein synthesis-inducing cues activate mTOR in a concentration-dependent
manner, which results in the asymmetric activation of the protein synthesis machinery
within the growth cone10,53,56,151.
mTOR activity is positively regulated by a GTP-bound form of RHEB GTPase, which is
inactivated by its GTPase-activating proteins TSC1 and TSC2 (REFS 132,133). TSC1 and
TSC2 are negatively regulated by AKT and ERK1/2 (REFS 132,133). Protein synthesis-
inducing cues can activate translation through the PI3K–AKT–mTOR pathway by
increasing PI3K or decreasing PTEN activities. For example, netrin 1 activates PI3K and
targets PTEN for ubiquitin-mediated proteolysis by activating the E3 ubiquitin-protein
ligase NEDD4 (REF. 78), but also through the mitogen-activated protein kinase (MAPK)–
TSC2–RHEB–mTOR pathway by activating MAPK ERK1/2 (in cases of netrin 1 (REF.
151), BDNF50 and SEMA3A151). By contrast, ephrin A reduces the activity of ERK1/2,
which results in a decreased inhibition of TSC2 and a decreased mTOR activity152. This
raises the interesting possibility that translational activity in growth cones could be regulated
through spatial and temporal integration of diverse receptor-mediated signalling pathways
converging on mTOR (FIG. 3). Cell contact-dependent changes in the cytoskeletal network
may also regulate translational activity, as the cytoskeleton directly associates with the
protein synthetic machinery and regulates mTOR activity153.
In addition to regulating mTOR, guidance cues may directly regulate ribosomes26. DCC
(deleted in colorectal carcinoma), a netrin 1 receptor, directly binds to ribosomal protein L5,
a component of the 60S ribosomal subunit30. Binding of netrin 1 to DCC activates
translational initiation and subsequently releases the ribosome–mRNA complex from DCC,
thereby allowing more ribosomes to form polysomes in the vicinity of receptor activation.
This provides a crucial mechanism for the localized control of mRNA translation near the
site of signal activation and may also prevent unnecessary translation in the basal state by
sequestering ribosomes. It will be of interest to determine whether other receptors show
similar interactions with the translational machinery.
mRNA transport and axonal mRNA repertoire
Axonal transcriptome analyses from diverse neurons — including microarrays studies in X.
laevis, mouse embryonic retinal ganglion cells16, rat embryonic and perinatal cortical and
hippocampal neurons aged to maturity in culture18 and rat embryonic and adult peripheral
sensory neurons17, and a sequential analysis of gene expression study in rat perinatal
sympathetic neurons15 — identified thousands of different mRNAs in their axons. Notably,
these axons contain common mRNAs, mainly those encoding protein synthesis machinery,
mitochondrial proteins and components of the cytoskeleton (TABLE 2). However, some
mRNAs were enriched in axons of specific cell types (for example, Impa1 mRNA is found
in peripheral15,17 but not central16,18 neuronal axons, and Creb mRNAs are found
exclusively in peripheral sensory neuronal axons17,61). Comparative bioinformatics analyses
revealed that specific anterograde transport is likely to account for mRNA enrichment in
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axons15 and growth cones16. Axonal transcriptomes change dynamically during
development, even in the same axons16, which suggests that axons may recruit specific and
biologically relevant mRNAs using active transport.
The cis-acting localization elements that target mRNAs to axons have been identified only
for a few mRNAs, such as β-actin mRNA154,155. Recent evidence shows that alternative
transcription termination produces mRNAs that are targeted to distinct neuronal subcellular
compartments (FIG. 4). Notably, a longer 3′-UTR targets Ranbp1 mRNA to adult sciatic
nerve66, and a distinct 3′-UTR element targets Impa1 mRNA into developing sympathetic
axons in response to NGF stimulation15. Furthermore, cis-acting elements can be
differentially regulated by extrinsic cues. In cultured adult peripheral sensory neurons, for
example, NGF, BDNF, NT3, SEMA3A and myelin-associated glycoprotein (MAG)
stimulation results in cue-specific mRNA axonal repertoires, thereby suggesting that
extrinsic stimuli recruit specific mRNAs156. RBPs directly associate with target mRNAs to
form transport ribonucleo-protein particles (RNPs), the components of which may directly
associate with molecular motors to mediate bidirectional axonal transport on
microtubules157. For example, the RBP La binds and promotes translation of mRNAs
containing the 5′-terminal oligopyrimidine tract (TOP) sequence in their 5′-UTRs158,159. In
axons, unmodified La interacts with the kinesin motors and mediates anterograde transport
of RNPs, but La switches to interact with the retrograde dynein motor upon sumoylation158.
Short-range RNP movements are likely to be mediated by myosin on actin filaments53,54,160
and can be regulated by extracellular signals53,54,156. RNA granules may also switch
between microtubule and microfilament tracks141. mRNAs are translationally repressed
during transport and remain silent in RNA granules until released for translation161. Co-
translational transport mechanisms might regulate subcellular localization of mRNAs
according to the properties of proteins they encode, as seen in budding yeasts, in which
actively translating ABP140 mRNA is tethered to actin filaments162. Upon completion of
translation, mRNAs can again associate with different RNA granules, such as transport
RNPs, stress granules that sequester non-essential mRNAs upon cellular stress, and
processing bodies (P bodies) where mRNAs are stored or degraded163.
mRNA-specific translation
Protein synthesis-inducing cues increase global translational activity but initiate translation
of only a subset of mRNAs. For example, netrin 1 and bdnf, but not en1, induce axonal
translation of β-actin mRNA in X. laevis retinal axons, whereas all three cues increase
global translational activity53,54,118. Furthermore, cues that increase global protein synthesis
can also repress translation of some mRNAs. For example, en1 increases overall axonal
protein synthesis in cultured X. laevis retinal axons but decreases the translation of heat
shock protein 70 (hsp70) mRNA118. How different extracellular signals activate the
translation of functionally coherent subsets of mRNAs is largely unknown.
Most known mRNA cis-acting elements reside in 3′-UTRs, including those in β-actin,
RHOA, EPHA2, cytochrome c oxidase subunit IV isoform 1 (COX4I1) and IMPA1
mRNAs15,23,41,116,154, but they can also be localized to 5′-UTRs (such as that of KOR1
mRNA)164, protein coding regions (such as that of ROBO3 mRNA)84 and potentially to
introns (as found in some dendritically targeted RNAs)165. Intron-retaining mRNAs in axons
(such as ROBO3 mRNA)166 may be prone to nonsense-mediated decay in P bodies, a
mechanism that is also regulated by extracellular cues167.
Trans-acting molecules regulate mRNA transport, stability and translation by reversibly
associating with specific mRNAs to form RNA granules168. Components of RNA granules,
such as RBPs and microRNAs, localize to axons and growth cones, and can be regulated by
extrinsic cues. For example, SRC-dependent phosphorylation of ZBP1 (REF. 71) is required
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for BDNF-induced β-actin synthesis and growth cone turning169. Conformational changes
induced by ZBP1 binding170 or translational de-repression from ZBP1 (REF. 71) may
promote the translation of β-actin mRNA.
FMRP is an RBP that recognizes target mRNAs based on their secondary structure171 and
represses their translation. The translational repression by FMRP is relieved by its
dephosphorylation by protein phosphatase 2A, which can be activated by neuronal
activity172. FMRP localizes to axons and growth cones and regulates cue-responsive local
mRNA translation in axons96,97.
Cytoplasmic polyadenylation element binding proteins (CPEB1, CPEB2, CPEB3 and
CPEB4) are translational repressors that recognize a specific sequence element173. CPEB1 is
required for NT3-induced axonal translation of β-catenin mRNA and axon branching in
cultured rat hippocampal neurons174. Blocking CPEB function by overexpressing a
dominant negative mutant impairs elongation of X. laevis retinal axons in vivo, but
knocking down CPEB1 expression does not, suggesting tissue-specific function of CPEB
isoforms175. These findings are consistent with a recent study using transgenic mice, which
showed that CPEB1 inhibits the translation of Pten mRNA176.
MicroRNAs are another class of trans-acting elements that could regulate mRNA translation
in a sequence-specific manner. Axons and growth cones contain functional RNA
interference machinery55, and microRNAs repress the translation of their target mRNA in
RNA granules until stimulated177. Recent evidence indicates that a single microRNA can
regulate the translation of functionally related mRNAs, as miR-338 inhibits axonal
translation of mRNAs encoding COX4I1 (REF. 178) and ATP5G1 (ATP synthase, H+
transporting, mitochondrial Fo complex, subunit C1 (subunit 9))117, the components of
mitochondrial complexes IV and V, respectively. These translational regulators are likely to
interact, as FMRP associates with ribosomes179, microRNAs180, and other RBPs such as
SMN1 (REF. 146).
Finally, receptor–ribosome interactions could potentially regulate mRNA-specific
translation. Expression of individual ribosomal proteins shows tissue specificity181, which
suggests that variable compositions of ribosomes may exist. Intriguingly, each composition
may preferentially translate specific mRNAs, as mutant mice that are hypomorphic for the
ribosomal protein L22 show specific defects in translation of related Hox mRNAs181.
Considering that guidance cue receptors may regulate mRNA translation by sequestering
ribosomes26, it is tantalizing to speculate that different extracellular signals might release
different ribosomes that are pre-tuned to translate a specific subset of mRNAs. It is
intriguing that axons and growth cones contain mRNAs encoding most ribosomal
proteins15–18,156, which themselves are regulated by mTOR through their 5′-TOP
sequences159, and there is evidence that at least some ribosomal proteins can be exchanged
in the cytoplasm182. Thus, axons might be able to fine-tune mRNA selectivity by
dynamically modifying ribosomal compositions using locally synthesized ribosomal
proteins.
Summary and future directions
Local mRNA translation is widely used to maintain subcellular autonomy in axons and
dendrites. Here, we have focused our attention on various stimulus-driven axonal responses,
such as growth cone chemotropic responses and axon regeneration, but evidence also
suggests that local mRNA translation might contribute to the maintenance of the steady state
of the local proteome in the distal axons9. Axonal mRNA translation occurs during
development and in adulthood, but the ability of axons to activate translational machinery is
closely associated with their ability to regenerate. Axons store neuronal subtype-specific and
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age-specific repertoires of local mRNAs, and translation of a specific subset of mRNAs is
likely to determine the nature of extrinsic cue-induced axonal responses (FIG. 5).
Recent advances in compartmentalized cell culture techniques36,183–185 (BOX 1) have
provided tools to study local mRNA translation in axons, and several candidate-based
approaches have revealed crucial insights into the role of axonal mRNA translation. The
unexpected complexity of axonal transcriptomes15–18 indicates that many biological
pathways are post-transcriptionally regulated in axons. In order to understand the roles that
local mRNA translation may have in vivo, it will be important to investigate which of these
axonally localized mRNAs are translated. It is possible to isolate axonally translating
mRNAs by affinity purification and axonally synthesized proteins by metabolic labelling
(BOX 1), although the minute amounts of these mRNAs and proteins makes it technically
challenging. Genome-wide correlative analyses of axonal transcriptomes and translatomes in
the context of extrinsic cue stimulation would provide insights into both axonal mRNA
translation and cue-mRNA specificity.
Another question to investigate is whether the complex axonal mRNA repertoire is a
property of individual axons or a collective property of diverse axons. Transcriptome
analyses have shown that axons of similar origins (such as dorsal root ganglia neurons,
sympathetic ganglia neurons or retinal ganglion cells) contain thousands of different
mRNAs, whereas immunocytological and ultrastructural evidence indicates that few
polysomes are present in individual axons. Information regarding the number and
distribution of mRNAs and protein synthesis machinery at the single axon level is needed to
improve our basic understanding of how mRNA translation is regulated in axons and to gain
insights into the puzzling paucity of polysomes and the apparent unconventional nature of
the axonal ER and Golgi apparatus.
Although candidate studies have identified several cis-acting elements that regulate axonal
mRNA localization, our knowledge about how specific mRNAs are selected for axonal
transport is limited. Most screening studies have used microarray techniques to identify
axonally localizing mRNAs, followed by rapid amplification of cDNA ends of individual
candidates to explore whether UTR diversity mediates selective axonal mRNA transport.
Recent advances in RNA sequencing technologies will provide new opportunities for
unbiased genome-wide screens for novel regulatory cis-acting elements that are not limited
to the UTRs.
Recent evidence using transgenic mice bearing a local translational reporter (BOX 1)
demonstrated that axonal mRNA translation occurs in vivo186, and the studies using
genetically modified mice with compromised functions of axonally localizing translational
regulators12,13,72,99,174 revealed potential roles that axonal mRNA translation may play in
vivo. However, direct evidence linking axonal mRNA translation to a specific function in
vivo is still scarce, because it is technically challenging to inhibit mRNA translation
specifically in axons in intact animals. One approach to address this point in candidate genes
is to introduce targeted mutations to known axon-localization elements in the UTRs, which
would result in normal protein expression but the specific loss of axonal mRNA localization
and translation. This is analogous to an in vitro study, in which an axon-targeted isoform of
Impa1 mRNA was selectively targeted by siRNA15. Another candidate approach involves
delivering caged translation-blocking antisense oligonucleotides, which can be activated by
local light stimulation in axons187, to specific neurons. These methods may provide ways to
inhibit the translation of a specific mRNA in axons in live animals. Intriguingly, a novel
method to inhibit translation of all mRNAs in presynaptic terminals in mouse brain slices
was recently developed: an inactive chemically inducible, genetically encoded translational
inhibitor was expressed in a specific subset of neurons and the activating chemical was
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locally applied to their axons62,188. Imaginative new approaches along these lines that
facilitate axon-specific inhibition of mRNA translation in vivo are needed to fully uncover
the role of local synthesis in nervous system assembly, maintenance and repair.
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Glossary
Polysomes Strings of 80S ribosomes bound to mRNA molecules.
Ribosomes Large RNA–protein complexes (80S) at which mRNA
translation occurs. They contain 4 rRNAs and more than 79
proteins and are composed of a large (60S) subunit and a small
(40S) subunit.
RNA-binding protein
(RBP)
A protein that binds RNAs. Most RBPs have modular
structures containing specific RNA-binding domains, catalytic
domains and/or protein-binding domains.
Small nuclear
ribonucleoproteins
(snRNPs)
Complexes that are composed of a small nuclear RNA and a
specific set of proteins.
RNA granules Intermediate RNA–protein complexes that regulate RNA
transport, translation and degradation. RNA granules include
transport ribonucleoproteins, stress granules and processing
bodies.
Stress granules Dense cytosolic proteins and RNA aggregations that appear
under conditions of cellular stress. The RNA molecules are
thought to be stalled translation pre-initiation complexes.
MicroRNAs Non-coding RNA molecules of 21–24 nucleotides in length
that inhibit mRNA expression.
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Box 1
Methods used to understand axonal mRNA translation and transport
Axonal mRNA isolation and transcriptome analysis
The accurate description of subcellular compartment-specific mRNA repertoires16–18
provides invaluable information regarding axonal mRNA transport and translation. The
axons of cultured neurons are separated from their cell bodies using compartmentalized
culture systems15,17,18 or laser-capture microdissection16. The Campenot chamber (see
the figure, part a)185,189, made of a Teflon divider attached to a petri dish, has two
compartments with distinct fluid environments. The proximal compartment contains cell
bodies, dendrites and proximal axons, whereas the distal compartment contains distal
axons. Typically, the distal compartment is supplemented with nerve growth factor
(NGF), which promotes the growth of peripheral sensory61 and sympathetic neurons15.
The microfluidic culture platform (see the figure, part b)18,183 has two mirror-imaged
compartments. Dissociated neurons are added to the somal compartment, and axons grow
into the axonal compartment through microgrooves. In laser-capture microdissection (see
the figure, part c)16, cultured neurons labelled with a fluorescent lipophilic dye are fixed,
and then axons or growth cones (indicated by white arrows in the figure) are
microdissected individually. Because the amount of RNA obtained is minute,
amplification is required before microarray analysis. This method, however, enables
subcellular compartment-specific comparison, which is not possible in
compartmentalized culture systems.
Quantitative immunofluorescence
The relative amount of a specific protein in cultured axons can be measured using
quantitative immunofluorescence. Cultured axons without somas are treated with a
protein synthesis-inducing cue with or without translational inhibitors and then fixed. The
protein of interest is visualized by immunofluorescence. Background-subtracted average
fluorescent intensity per unit area in axons or growth cones represents the relative protein
amount10. An increase in protein quantity in axons without somas that is blocked by a
translational inhibitor probably results from axonal mRNA translation.
Live imaging of translational reporter fluorescence
For mRNAs whose cis-acting translational regulatory element is known, translation can
be visualized in real-time using a fluorescent reporter whose translation is regulated by
the same cis-acting element. Diffusion-limited and short-lived fluorescent proteins are
common translational reporters and their appearance indicates local mRNA
translation61,186. Another class of reporter molecules is photoconvertible fluorescent
proteins: the appearance of new fluorescent proteins after irreversible photoconversion of
pre-existing proteins indicates local mRNA translation53,190.
Visualization of mRNAs and RNA-binding proteins
An mRNA can be directly visualized by delivery of in vitro-transcribed mRNAs that
have incorporated fluorescent nucleotides191 into neurons by electroporation or
microinjection. Alternatively, mRNAs can be visualized indirectly using the sequence-
specific interaction of MS2 bacteriophage RNA hairpin and capsid protein (known as
MS2 tagging)191. An mRNA fused to the MS2 binding site is co-expressed with a
fluorescent MS2 protein, and the mRNA is visualized by MS2 fluorescence in axons192.
MS2 tagging enables endogenous mRNAs to be labelled by generating MS2 binding site-
containing knock-in mice193. RNA-binding proteins fused to a fluorescent protein can
also be visualized53. Extracellular cue-induced changes in localization of mRNAs and
RNA-binding proteins can be visualized in real-time or after fixation, and are commonly
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quantified by examining the behaviours of individual fluorescent particles or the
distribution of total fluorescent particles53.
Unbiased screening of de novo proteome or translatome
De novo proteins in axons that do not have somas or glia in culture can be metabolically
labelled (for example, using radioactive methionine), separated by two-dimensional
electrophoresis, and identified by mass spectrometry. A challenge is to obtain sufficient
amounts of axonally synthesized proteins, which are estimated to account for less than
5% of total protein synthesis in cultured sympathetic neurons194. Recently developed
click chemistry enables extremely sensitive labelling of newly synthesized proteins195
and was successfully applied to visualize axonally synthesized proteins118. Alternatively,
the translatome can be described196. Axonally translating mRNAs can be isolated by
immunoprecipitating ribosomes and associated mRNAs specifically from axons118. For
example, a tagged ribosomal protein can be specifically expressed in the eye, and
ribosome–mRNA complexes can be isolated from the brain, in which the only source of a
tagged ribosome is the retinal axons118.
Figure part a is modified, with permission, from REF. 185 © (2009) Macmillan
Publishers Ltd. All rights reserved. Part b is modified, with permission, from REF. 183 ©
(2005) Macmillan Publishers Ltd. All rights reserved. Part c is reproduced, with
permission from REF. 16 © (2010) Society for Neuroscience. Scale bar represents 150
μm.
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Figure 1. Growth cone turning regulated by differential mRNA translation
Gradients of protein synthesis-inducing guidance cues commonly activate global
translational activity on the side of the growth cone nearest to the gradient by activating
mammalian target of rapamycin (mTOR). However, the specific mRNA translated in
response to the cue differs depending on whether it is an attractive or repulsive cue and
determines the direction of growth cone turning. a | Stimulation by attractive cues, such as
netrin 1 and brain-derived neurotrophic factor (BDNF), leads to asymmetric synthesis of β-
actin on the side near to the source of the gradient, which is mediated by β-actin mRNA
transport to this region by zipcode-binding protein 1 (ZBP1)53,54. Spatially restricted
synthesis of β-actin may lead to actin polymerization, cytoskeletal assembly and attractive
turning of the growth cone. b | By contrast, repulsive cues, such as semaphorin 3A
(SEMA3A) and SLIT2, activate the axonal translation of the actin-depolymerizing proteins
RHOA55 and cofilin56 when uniformly applied in cell culture. A proposed model is shown,
in which localized cytoskeletal disassembly may result in repulsive turning through
polarized filopodial collapse. However, whether these molecules are translated
asymmetrically in a repulsive gradient has not yet been tested.
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Figure 2. Axon survival, maintenance and injury-induced responses regulated by local protein
synthesis
a | Distal axons receive target-derived trophic factors. These target-derived cues activate
local synthesis of mitochondrial, signalling or nuclear proteins required for axon
maintenance and cell survival. Stimulation of axons with nerve growth factor (NGF) results
in local synthesis of cyclic AMP responsive element-binding protein (CREB), which is then
locally phosphorylated61. This active form of axonal CREB is transported into the nucleus
and is required for axon survival in cultured sensory neurons61. NGF also stimulates the
axonal synthesis of inositol monophosphatase 1 (IMPA1), an enzyme that regulates the
inositol cycle. Axonally synthesized IMPA1 may regulate retrogradely transporting vesicles
and is required for axon survival in cultured sympathetic neurons15. Distal axons also
synthesize nuclear-encoded mitochondrial proteins, and sustained local synthesis and
mitochondrial import of such proteins are required for axon maintenance in cultured
neurons117. Lamin B2, a known nuclear envelope component, is also axonally synthesized
and localized to mitochondria in distal axons, and sustained axonal synthesis of lamin B2 is
required for axon maintenance in vitro and in vivo118. b | Nerve injury generates a
retrograde survival and/or repair signal, and local protein synthesis is required for its
generation and relay to the nucleus. The retrograde dynein motor complex is inactivated by
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Ran GTPase in normal conditions. Nerve injury stimulates local synthesis of Ran-specific
GTPase-activating protein (RANBP1), which displaces Ran from the dynein motor66.
Importin-β1 is also locally synthesized in response to nerve injury and binds to the Ran-free
dynein motor complex, which results in the activated dynein motor complex64.
Transcription factors, such as signal transducer and activator of transcription 3 (STAT3), are
also locally synthesized and activated in injured axons and bind to the activated dynein
motor complex using the nuclear localization signal14. A type III intermediate filament
vimentin is also locally synthesized in injured axons and co-transported with other signalling
molecules that bind to it65.
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Figure 3. Regulation of global translational activity through mTOR
Cues that induce and inhibit protein synthesis antagonistically regulate the activity of
mammalian target of rapamycin (mTOR), which regulates cap-dependent mRNA translation
by phosphorylating its two major targets: eukaryotic translation initiation factor 4E (eIF4E)-
binding protein 1 (4E-BP1) and ribosomal protein S6 kinase (S6K). Protein synthesis-
inducing cues, such as netrin 1 or brain-derived neurotrophic factor (BDNF), may increase
mTOR activity through the AKT–mTOR pathway by activating phosphoinositide 3-kinase
(PI3K)10 or by promoting ubiquitin–proteasome system (UPS)-mediated degradation of
phosphatase and tensin homologue (PTEN)78, or through the mitogen-activated protein
kinase (MAPK)–mTOR pathway by activating MAPK extracellular signal-regulated kinase
1 and 2 (ERK1/2)50,151 that inhibits the mTOR negative regulators tuberous sclerosis protein
1 (TSC1) and TSC2. Some cues, such as ephrin A, can inhibit protein synthesis by inhibiting
ERK1/2 leading to TSC1/2 activation and mTOR inhibition152. Spatiotemporal summation
of cue-induced signals converging on mTOR might lead to asymmetric translational activity.
DCC, deleted in colorectal carcinoma (netrin 1 receptor); PDK1, 3-phosphoinositide-
dependent protein kinase 1; PIP2, phosphatidylinositol-4,5-bisphosphate (also known as
PtdIns(4,5)P2); PIP3, phosphatidylinositol-3,4,5-triphosphate (also known as
PtdIns(3,4,5)P3).
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Figure 4. RNA-specific transport and translation
Axonal targeting of mRNAs is directed by cis-acting elements that are mainly localized to
the 3′-untranslated regions (UTRs) of mRNAs. Retention of these axon-targeting cis-acting
elements is commonly regulated by the use of different transcriptional termination sites15,66.
Extrinsic cues influence axonal mRNA repertoires by promoting transport of specific
mRNAs156. Axonally targeted mRNAs are recruited to RNA granules (transport
ribonuceloproteins (RNPs)) by specific RNA-binding proteins (RBPs) and are transported
along microtubules probably by kinesin motors157. mRNAs remain translationally silent
during transport21. Extracellular signals activate the translation of specific mRNAs mainly
by regulating RBPs. For example, neurotrophins and guidance cues activate the kinases
SRC71, calcium/calmodulin-dependent protein kinase II (CaMKII)174 and focal adhesion
kinase (FAK)164, which phosphorylate the RBPs, zipcode binding protein 1 (ZBP1),
cytoplasmic polyadenylation element binding protein (CPEB1), and growth factor receptor-
bound protein 7 (GRB7), respectively. Cell surface receptors might regulate mRNA-specific
translation by directly regulating ribosomes. For example, unstimulated netrin receptor DCC
directly binds to ribosomes and inhibits translation26, and ribosome composition influences
mRNA selectivity181. Different receptors may bind to ribosomes that are pre-tuned to
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specific mRNAs, and ligand stimulation might release such ribosomes and result in mRNA-
specific translation. BDNF, brain-derived neurotrophic factor; KOR1, κ-type opioid
receptor; NT3, neurotrophin 3; TRK, tyrosine kinase receptor.
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Figure 5. Local mRNA translation as a mediator of stimulus-induced axonal responses
A proposed model for the function and mechanism of axonal mRNA translation. Neuronal
axons contain a complex and dynamic transcriptome, and many mRNAs remain
translationally silent. Various extrinsic cues stimulate translation of a distinct subset of
mRNAs during development and in adulthood. For example, guidance cues induce local
synthesis of cytoskeletal proteins in growing axons and regulate axon guidance and
branching. Target-derived trophic factors promote local synthesis of proteins required for
mitochondrial function and support the survival of distal axons. Nerve injury in adulthood
stimulates local synthesis of nuclear factors that activate repair mechanisms.
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Table 1
Signals that regulate axonal mRNA translation
Signal Neuronal type Target mRNA Regulator Function Refs
Signals that increase axonal protein synthesis
Netrin 1 RGC* β-actin ZBP1 GC turning 53
P19 KOR1 GRB7 Analgesia 164
DRG‡ PAR3 Unknown Axon elongation 52
Semaphorin 3A DRG‡ RHOA Unknown GC collapse 55
DRG‡ Calreticulin Unknown Axon regeneration 156
SLIT2B RGC* Cofilin Unknown GC collapse 56
Nerve growth factor PC12 Unknown Unknown Neurite regeneration 114
PC12 RPL4 Unknown Neurite regeneration 197
Sympathetic§ β-actin, ADF, NF Unknown Axon guidance¶ 194
Sympathetic‡ IMPA1 Unknown Axon maintenance 15
Hippocampal‡, CTX‡ β-actin Unknown Axon guidance¶ 63
DRG‡ β-actin Unknown Axon regeneration 156
DRG‡ CREB Unknown Cell survival 61
DRG‡ PAR3 Unknown Axon elongation 52
SCG‡ COX4I1 miR-338 Axon maintenance 116,178
SCG‡ ATP5G1 miR-338 Axon maintenance 198
PC12 GAP43 HUD Axon guidance¶ 103
SMN‡ CPG15 SMN and HUD Axon maintenance 12
Brain-derived neurotrophic factor Spinal cord* β-actin ZBP1 GC turning 54
Hippocampal‡, CTX‡ β-actin ZBP1 Axon guidance¶ 63
DRG‡ β-actin ZBP1 Axon regeneration 156
Spinal cord‡, SMN‡ CPG15 SMN and HUD Axon maintenance 12
Neurotrophin 3 Hippocampal‡ β-catenin CPEB1 Axon branching 174
DRG‡ β-actin ZBP1 Axon regeneration 156
DRG‡, CTX‡ Calreticulin Unknown Axon guidance 155
Pituitary adenylate
cyclase-activating polypeptide
Spinal cord* Unknown Unknown GC turning 60
5-hydroxytryptamine (serotonin) Sensory∥ eEF1A Unknown Long-term facilitation 199
Myelin-associated glycoprotein DRG‡ αB crystallin Unknown Axon regeneration 156
DRG‡, CTX‡ Calreticulin Unknown Axon guidance¶ 155
Engrailed 1 and 2 RGC*‡§ Unknown Unknown Topographic mapping 58,59
RGC* Lamin B2 Unknown Axon maintenance 118
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Signal Neuronal type Target mRNA Regulator Function Refs
Midbrain
dopaminergic‡
COX1 components Unknown Cell survival 57
Axotomy DRG‡ Importin-β Unknown Axon regeneration 64
DRG‡ Vimentin Unknown Axon regeneration 45,65
DRG‡ STAT3A Unknown Axon regeneration 14
DRG‡ NF-L, NF-M, NF-H Unknown Axon regeneration 200
Differentiation P19 Tau Unknown Axon elongation 201
Unknown OSN‡ Odorant receptors Unknown Axon regeneration 128
Unknown Caenorhabditis elegans C/EBP1 MAPK Axon regeneration 130
Depolarization DRG‡ KOR1 Unknown Analgesia 42
Inflammation DRG‡ TRPV1¶ Unknown Hyperalgesia 134
Injury DRG‡ Nav1.8 Unknown Hyperalgesia 135,137
Signals that do not increase axonal protein synthesis
Ephrin B RGC* Not applicable Not applicable Not applicable 67
Lysophosphatidic acid RGC* Not applicable Not applicable Not applicable 10
Signals that decrease axonal protein synthesis
Ephrin A RGC‡ Unknown ERK1/2 and TSC1/2 Axon guidance 152
ADF, actin depolymerizing factor; ATP5G1, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9); C/EBP1, CAAT
enhancer binding protein 1; COX1, cyclooxygenase 1; COX4I1, cytochrome c oxidase subunit IV isoform 1; CPEB1, cytoplasmic polyadenylation
element binding protein 1; CPG15, translation of candidate plasticity-related gene 15 (also known as NRN1); CREB, cyclic AMP responsive
element-binding protein; CTX, cerebral cortical; DRG, dorsal root ganglion; eEF1A, eukaryotic elongation factor 1α; ERK, extracellular signal-
regulated kinase; GAP43, growth associated protein 43; GC, growth cone; GRB7, growth factor receptor-bound protein 7; HUD, Hu-antigen D
(also known as ELAVL4); IMPA1, inositol monophosphatase 1; KOR1, κ-type opioid receptor; MAPK, mitogen-activated protein kinase; miR,
microRNA; Nav1.8, sodium channel 1.8; NF (L, M, H), neurofilament protein (light, medium, heavy); OSN, olfactory sensory; PAR3, proteinase-
activated receptor 3; RGC, retinal ganglion cell; RPL4, ribosomal protein L4; SCG, superior cervical ganglion; SMN, spinal motor neuron;
STAT3A, signal transducer and activator of transcription 3A; TRPV1, transient receptor potential cation channel subfamily V member 1; TSC,
tuberous sclerosis protein; ZBP1, zipcode binding protein 1.
*Xenopus laevis.
‡
Mouse or rat.
§Chicken.
∥Aplaysia.
¶
Indicates that the finding was not directly addressed in the study.
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Table 2
Selected functional categories of axonally enriched mRNAs
Neuronal type Subcellular
compartment
Protein
synthesis
Mitochondrial Cytoskeletal Cell–cell
signalling
Ref.
Rat
Embryonic SCG Axons Yes Yes Yes No 64
Embryonic DRG Axons Yes Yes Yes No 65
Adult DRG Young growth
cones
Yes Yes Yes Yes 65
Neonatal
cerebral cortical
Axons (cultured
to maturity)
Yes Yes Yes No 66
Xenopus laevis
Embryonic RGC Young growth
cones
Yes Yes Yes No 67
Embryonic RGC Old growth
cones
Yes Yes Yes Yes 67
Mouse
Embryonic RGC Growth cones Yes Yes Yes No 67
DRG, dorsal root ganglion; RGC, retinal ganglion cell; SCG, superior cervical ganglion.
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